Near-Infrared Spectroscopy for Pediatric Acute Scrotum and Testicular Torsion (NIRS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01812109|
Recruitment Status : Completed
First Posted : March 15, 2013
Results First Posted : January 29, 2021
Last Update Posted : January 29, 2021
- Study Details
- Tabular View
- Study Results
- How to Read a Study Record
|First Submitted Date ICMJE||January 24, 2013|
|First Posted Date ICMJE||March 15, 2013|
|Results First Submitted Date ICMJE||November 24, 2020|
|Results First Posted Date ICMJE||January 29, 2021|
|Last Update Posted Date||January 29, 2021|
|Actual Study Start Date ICMJE||March 24, 2011|
|Actual Primary Completion Date||March 25, 2015 (Final data collection date for primary outcome measure)|
|Current Primary Outcome Measures ICMJE
||Median NIRS Delta %StO2 [ Time Frame: Done at 1, 5 and 10 seconds ]
Testicular tissue percent oxygen saturation (%StO2) is measured by transscrotal near infrared spectroscopy (NIRS). This is similar to the PulseOx machine that is usually used when we go for a regular doctor visit. NIRS measurements were obtained with Hutchison Technology InSpectra StO2 Spot Check Device (Model 300) with thenar clip probe (Model 1315, modified by clip removal). Measurements were done at 1, 5 and 10 seconds to account for interassay variability, which is expected to be less than 3 %StO2. The average of the 3 readings was defined as the NIRS %StO2 reading for that testis. The NIRS readings in the affected testis were normalized to the contralateral normal testis to formulate a NIRS delta %StO2 (%StO2 of unaffected testis and %StO2 of affected testis). If the affected testis had lower %StO2 readings than the contralateral normal testis, NIRS delta %StO2 would be positive.
|Original Primary Outcome Measures ICMJE
||Testicular oxygen saturation (%StO2) [ Time Frame: Baseline, At surgery, One hour after surgery, 2 weeks postop ]
Baseline transcutaneous testicular %StO2 is at presentation to the ER for acute scrotum. Study personnel are blinded to results so as to not change standard of care. Baseline %StO2 will be compared to US diagnosis of torsion. At surgery is direct testicular %StO2. One hour after surgery and two weeks postop are transcutaneous testicular %StO2.
|Current Secondary Outcome Measures ICMJE||Not Provided|
|Original Secondary Outcome Measures ICMJE||Not Provided|
|Current Other Pre-specified Outcome Measures||Not Provided|
|Original Other Pre-specified Outcome Measures||Not Provided|
|Brief Title ICMJE||Near-Infrared Spectroscopy for Pediatric Acute Scrotum and Testicular Torsion|
|Official Title ICMJE||Near-Infrared Spectroscopy for Pediatric Acute Scrotum and Testicular Torsion|
|Brief Summary||Testicular torsion is the spontaneous twisting of the testis and its blood vessels, resulting in acute pain, vascular compromise and death of the testicle if unrelieved quickly. In this study, investigators will test a near-infrared spectroscopy (NIRS) device that rapidly and non-invasively measures deep tissue oxygen saturation.|
The main goal of this prospective, non-randomized pilot study is to assess the utility of NIRS for the clinical diagnosis of the acute scrotum and testicular torsion. The sensitivity and specificity of NIRS for testicular torsion will be defined relative to surgical exploration, scrotal Doppler/B-mode ultrasound, and clinical follow-up. Last, we will assess the utility of intraoperative and postoperative NIRS for predicting testicular viability after testicular detorsion. To achieve this, standard care will be provided for all patients and at two or five time points NIRS measurements will be obtained privately so standard care is not biased by NIRS data. Outcome variables will include NIRS StO2 ( percent oxygen saturation) measurements, torsion status (yes/no), ultrasound parameters (testicular size, volume, echogenicity, presence/absence of Doppler flow, whirlpool sign, hydrocele, scrotal wall thickness), TWIST score variables, duration of pain, and duration of torsion. Study endpoints will include early withdrawal, screen failures, orchiectomy for torsion, and 1-2 week or 3 month post-surgical follow-up (see Figure 1). In this 5 year single center study, the maximum number of local subjects to be consented will be 750 subjects. No existing charts will be used in this prospective study.
Patients with acute scrotum will be evaluated by history, physical examination, and urinalysis per standard of care by staff in the ER, pediatric urology or pediatric surgery. At the surgeon's discretion, either a scrotal Doppler/B-mode ultrasound or emergent surgical exploration will be planned as the next step per standard of care. While waiting for preparation of either the scrotal Doppler/B-mode ultrasound or emergent surgical exploration, the patient and guardian will be informed and invited for study participation. If they agree to participate, they will be given a Fitzpatrick Skin Type (FST) Survey. This survey is a classification scale that was created in 1975 for predicting skin reactivity in PUVA (Psoralen plus ultraviolet A) photochemotherapy.  This survey asks the subject to grade his tendency to burn and ability to tan respectively within 24 hours and 7 days after the first un-protected sun-exposure in the early summer. There are four possible answers for "white"-skinned persons (skin type I, II, II, IV). Brown skin classification is skin type V and black skin classification is skin type VI. In the event that the survey has been missed, we will mail a survey to the patient/guardian with a pre-stamped and addressed return envelope.  Those that refuse study participation will receive standard of care treatment for the acute scrotum.
Those that accept study participation after informed consent will receive standard of care therapy for the acute scrotum and will be evaluated by NIRS. The NIRS measurements will not bias the treatments performed or not performed on the study patients, permitting standard of care treatment unbiased. The clinical data will be collected prospectively for each patient utilizing REDCap Data Collection Management and stored in the REDCap databases and the photographic database. Photographs will be taken of the scrotum. In addition, select participants will be asked if they will allow us to videotape the NIRS measurements.
At the surgeon's decision and discretion, either a scrotal Doppler/B-mode ultrasound or emergent surgical exploration will be planned as the next step per standard of care. While waiting for this to occur, the NIRS #1 measurement will be obtained. NIRS #1 is a series of 6 transcutaneous scrotal measurements, three on the left and three on the right. Each measurement is completely non-invasive, painless and takes <15 seconds each. Thus, no sedation or supplemental analgesia will be needed for NIRS. The NIRS probe will be placed on the anterior scrotum on the left and right sides, immediately overlying the testis but on the skin, to obtain the six total measurements. Thus, the unaffected testis will serve as the patient's own control. NIRS #1 will not delay the scrotal Doppler/B-mode ultrasound or emergent surgical exploration.
If the surgeon decides against surgical exploration, then standard care for the other causes of acute scrotum will be provided and the diagnosis will be no testicular torsion. The patient will be discharged home with a standard care follow-up in approximately two weeks in an outpatient urology clinic appointment. The subject will be given a NIRS Daily Diary to take home with them and record a five-day history of pain and recovery course. They will be asked to bring this back at the two week follow-up visit.
If the scrotal Doppler/B-mode ultrasound identifies testicular torsion or if the surgeon feels emergent surgical exploration is indicated, then emergent surgical exploration will be performed. Photographs of the scrotum will be obtained, as well as select patients to be consented for videotaping of the NIRS measurements At surgery under general anesthesia per standard care, NIRS #2-4 will be performed. NIRS #2-4 is a series of 18 testicular tissue measurements, nine on the affected testis and nine on the unaffected testis. Each testis will receive nine measurements, three thru the skin and six directly on the exposed testis (three prior to untwisting and three 5 minutes after untwisting). The probe will be laid on the exposed testis (intraoperative testicular tissue). Each measurement is painless and takes <15 seconds each. The NIRS probe will be placed on the anterior testis to obtain the three sets of three measurements. Thus, the unaffected testis will serve as the patient's own control. NIRS #2-4 will not delay detorsion of the affected testis. Surgeons will be blinded to these NIRS results, thus the decision during the operation will not be affected.
In addition, using a standardized color wheel we have created, the surgeon will be asked to describe the color of the testis at the time of initial exposure and at 5 minutes after detorsion.
If testicular torsion is found and the torsed testis is nonviable after detorsion, the orchiectomy with contralateral orchiopexy will be performed per surgeon's decision. The patient will be discharged home and will reach study endpoint.
If testicular torsion is found and the torsed testis is viable after detorsion, then bilateral orchiopexy will be performed. One hour after the NIRS #2-4 measurements were completed, NIRS #5 will be performed using the method described for NIRS #1 only on postsurgical patients that underwent bilateral orchiopexy for testicular salvage.
At the time of discharge home, the subject will be given a NIRS Daily Diary to take home with them and record a five-day history of pain and recovery course. They will be asked to bring this back at the two week follow-up visit.
A phone interview will take place at day 5 to assess their postoperative pain course. A telephone script will be utilized if the patients fail to follow-up with the urology clinic. We will conduct this brief telephone interview with the parents/guardians as a means of follow-up.
1-2 weeks later, non-surgical patients and surgical patients having bilateral orchiopexy will return for an outpatient urology clinic evaluation of ~1 hour duration.
If the patient does not return at either the designated 1-2 weeks or three month follow-up outpatient urology clinic evaluation, then the PI and/or research nurse coordinator will telephone the guardian to encourage return to clinic and for verbal status report on the child's clinical state.
Thus, the total number of study visits, including the presenting emergency visit, is three (Emergency, 1-2 weeks post-operatively, and 3 months post-operatively). No medications will be administered in this study. No blood or tissue will be collected and no radiation exposure or questionnaires will be given. No subjects will be responsible for any research-related costs however; they will be responsible for standard care costs. At the end of the study, standard care will be turned over to the primary care physician or pediatric urologist if needed. No sub-study procedures will be performed.
|Study Type ICMJE||Interventional|
|Study Phase ICMJE||Not Applicable|
|Study Design ICMJE||Allocation: N/A
Intervention Model: Single Group Assignment
Intervention Model Description:
Those that accept study participation after informed consent will receive standard of care therapy for the acute scrotum and will be evaluated by NIRS. The NIRS measurements will not bias the treatments performed or not performed on the study patients, permitting standard of care treatment unbiased. The clinical data will be collected prospectively for each patient utilizing REDCap Data Collection Management and stored in the REDCap databases and the photographic database. Photographs will be taken of the scrotum. In addition, select participants will be asked if they will allow us to videotape the NIRS measurements.Masking: None (Open Label)
Primary Purpose: Diagnostic
The probe will be laid on the exposed testis (intraoperative testicular tissue). Each measurement is painless and takes <15 seconds each. The NIRS probe will be placed on the anterior testis to obtain the three sets of three measurements. Thus, the unaffected testis will serve as the patient's own control. NIRS #2-4 will not delay detorsion of the affected testis. Surgeons will be blinded to these NIRS results, thus the decision during the operation will not be affected.
All participants' NIRS results will be blinded to the surgeons.
|Intervention ICMJE||Device: Hutchison Technologies Inspectra StO2 SpotCheck Near-Infrared Spectroscopy
Device: Near-Infrared Spectroscopy Transscrotal NIRS is a series of 6 transcutaneous scrotal measurements, 3 on both left/right. Each measurement is completely non-invasive, painless and takes ~15 seconds each. Thus, no sedation or supplemental analgesia is needed for NIRS. The NIRS probe will be placed on the anterior, lateral and posterior scrotum on the left/right sides, immediately overlying and parallel to the long axis of the testis but on the skin to obtain the 6 total measurements. The unaffected testis will serve as the patient's own control. Study coordinators will be performing the ER transscrotal NIRS testing. For uniformity, all will be trained for testicular probe placement methods. NIRS will not delay the gray scale/color Doppler testicular US or surgery.
|Study Arms ICMJE||Experimental: Hutchison Technologies Inspectra StO2 NIRS
Hutchison Technologies Inspectra StO2 SpotCheck Near-Infrared Spectroscopy (NIRS) evaluation of acute scrotum per protocol
Intervention: Device: Hutchison Technologies Inspectra StO2 SpotCheck Near-Infrared Spectroscopy
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
|Recruitment Status ICMJE||Completed|
|Actual Enrollment ICMJE
|Original Estimated Enrollment ICMJE
|Actual Study Completion Date ICMJE||November 9, 2015|
|Actual Primary Completion Date||March 25, 2015 (Final data collection date for primary outcome measure)|
|Eligibility Criteria ICMJE||
Males one month to 21 years of age with:
Painful acute scrotum or testis OR Abdominal pain (+/- nausea, vomiting) and waddling gait ("cowboy shuffle") from painful scrotum.
Synchronous bilateral testicular torsion History of known testicular or scrotal surgery Current hernia or painless hydrocele Current obvious scrotal bug bites History of chronic respiratory, hematological or vascular problems that will affect total body tissue oxygenation levels (Home oxygen).
|Ages ICMJE||1 Month to 21 Years (Child, Adult)|
|Accepts Healthy Volunteers ICMJE||No|
|Contacts ICMJE||Contact information is only displayed when the study is recruiting subjects|
|Listed Location Countries ICMJE||United States|
|Removed Location Countries|
|NCT Number ICMJE||NCT01812109|
|Other Study ID Numbers ICMJE||STU 102010-133
1R21DK092654-01A1 ( U.S. NIH Grant/Contract )
|Has Data Monitoring Committee||Yes|
|U.S. FDA-regulated Product||
|IPD Sharing Statement ICMJE||Not Provided|
|Current Responsible Party||Linda A Baker, University of Texas Southwestern Medical Center|
|Original Responsible Party||Same as current|
|Current Study Sponsor ICMJE||University of Texas Southwestern Medical Center|
|Original Study Sponsor ICMJE||Same as current|
|Collaborators ICMJE||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|
|PRS Account||University of Texas Southwestern Medical Center|
|Verification Date||January 2021|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP